Oric Pharma director Richard A. Heyman disposes of common shares worth $86,518.47

• Oric Pharmaceuticals director Richard A. Heyman exercised stock options for 3,500 shares at $1.6 on Oct. 1, 2026.
• He sold 3,500 shares at $12.9141, leaving 38,300 shares owned directly.
• RAHD Capital, LLC sold 3,200 shares at $12.9141; beneficial ownership stood at 203,472 shares held indirectly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oric Pharmaceuticals Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001584759-26-000017), on October 02, 2026, and is solely responsible for the information contained therein.